Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 21,740 results that match your search.21,740 results
  • bae-nov02.jpg
    What estoppel means in Korea after Festo
    In July 2000, the Korean Supreme Court handed down its first decision specifically stating the requirements for the doctrine of equivalents. Afterwards, many other relevant precedent cases have also been decided in a rather short period of time.
    Managing IP Correspondent, November 01 2002
  • clark-nov02.jpg
    IN BRIEF: MOVES
    ? Australia: David Clark has become a partner of Blake Dawson Waldron in its Sydney office, where he will set up the office's patent services group. He previously was a partner of Griffith Hack.
    Managing IP Correspondent, November 01 2002
  • £4 million award for Dyson in UK
    Vacuum cleaner maker Dyson has pocketed over £4 million ($6.24 million) in a settlement with rival Hoover. The settlement - £4 million plus costs and interest - comes just weeks before the High Court was due to decide what level of damages should be awarded against Hoover.
    Managing IP Correspondent, November 01 2002
  • ibm-ip-licensing-nov02.gif
    Why exclusion is not profitable
    Licensing can generate millions of dollars for technology companies, but many executives still do not take full advantage of the opportunities available. Dan McCurdy and Marshall Phelps explode the myths that prevent companies from developing successful licensing programmes
    Managing IP Correspondent, November 01 2002
  • BMS faces pressure in Thailand
    An action to revoke its patent on the drug Videx EC threatens to limit further Bristol-Myers Squibb's (BMS) rights to sell Aids medicines in Thailand. Three Aids patients and the Foundation for Consumers, a local group, claim that the US pharmaceutical company did not invent the drug and so should not be allowed to own the rights to it in Thailand. According to the plaintiffs, the drug is a product of collaboration between BMS and the US National Institutes of Health (NIH).
    Managing IP Correspondent, November 01 2002
  • thomas-nov02.jpg
    An inexhaustible question
    One might have thought that the question of the exhaustion of trade marks in the European Economic Area (EEA) had been resolved, or at least stabilized, to a certain extent.
    Managing IP Correspondent, November 01 2002
  • prilosec-nov02.jpg
    AstraZeneca's purple pill under threat
    Pharma company AstraZeneca has stopped three generics from launching rival versions of its multi-billion dollar drug Prilosec in the US. But a fourth generic company is free to manufacture its own version of the drug.
    Managing IP Correspondent, November 01 2002
  • tsang-nov02.jpg
    How copyright rows are settled now
    Following promulgation by the State Council of the new Implementing Regulations on Copyright Law, the Supreme People's Court also promulgated a new Judicial Interpretation on Several Issues relating to the Application of Law in Adjudicating Civil Copyright Dispute Cases. The new Judicial Interpretation, which came into force on October 15 2002, clarifies certain issues on copyright disputes.
    Managing IP Correspondent, November 01 2002
  • KoreaSpeed is the key in fixing domain name rows
    Korea's method of resolving domain name disputes is less than a year old. The new system has already proved itself to be an efficient and cheap mechanism for dispute resolution, writes Jay (Young-June) Yang
    Managing IP Correspondent, September 30 2002
  • MalaysiaDealing with overruns and transhipments in Malaysia
    Linda Wang and Ooi Aik Hin, of Tay & Partners, explain how to deal with overruns and transhipments under the following situations
    Managing IP Correspondent, September 30 2002
Previous
1
...
2054
2055
2056
2057
2058
...
2173
Next